Anaplastic Lymphoma Kinase Rearrangement and Response to Crizotinib in Pancreatic Ductal Adenocarcinoma

被引：9
|
作者：
Tuli, Richard [1 ]
Lo, Simon [1 ]
Koo, Jaimie [1 ]
Pishvaian, Michael [2 ]
Bender, R. Joseph [2 ]
Petricoin, Emanuel [2 ]
Brody, Jonathan [2 ]
Nissen, Nicholas [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Perthera, Mclean, VA USA
来源：
JCO PRECISION ONCOLOGY | 2017年 / 1卷
关键词：
D O I：
10.1200/PO.17.00016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 5
页数：5
相关论文
共 50 条
  • [1] Melanoregulin-Anaplastic Lymphoma Kinase (ALK), a Novel ALK Rearrangement That Responds to Crizotinib in Lung Adenocarcinoma
    Wang, Leiming
    Yao, Shuyang
    Teng, Lianghong
    Zhang, Weiwei
    Chen, Li
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (03) : E44 - E46
  • [2] Crizotinib: an anaplastic lymphoma kinase inhibitor
    Gadgeel, Shirish M.
    Bepler, Gerold
    FUTURE ONCOLOGY, 2011, 7 (08) : 947 - 953
  • [3] Volatolomic signatures of anaplastic lymphoma kinase gene rearrangement in adenocarcinoma
    Hida, T.
    Oya, Y.
    Tanaka, K.
    Yoshida, T.
    Shimizu, J.
    Horio, Y.
    Yatabe, Y.
    Itoh, T.
    Shin, W.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S61 - S61
  • [4] Esophagitis resulting from treatment with crizotinib for anaplastic lymphoma kinase rearrangement-positive lung adenocarcinoma: A case report
    Takakuwa, Osamu
    Oguri, Tetsuya
    Yokoyama, Midori
    Hijikata, Hisatoshi
    Uemura, Takehiro
    Ohkubo, Hirotsugu
    Maeno, Ken
    Niimi, Akio
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (01) : 121 - 123
  • [5] Cytomorphological features of lung adenocarcinoma with anaplastic lymphoma kinase gene rearrangement
    Shukla, Saumya
    Husain, Nuzhat
    Gupta, Anurag
    Anand, Nidhi
    JOURNAL OF CYTOLOGY, 2019, 36 (01) : 8 - 12
  • [6] Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma
    Godbert, Yann
    de Figueiredo, Benedicte Henriques
    Bonichon, Francoise
    Chibon, Frederic
    Hostein, Isabelle
    Perot, Gaelle
    Dupin, Camille
    Daubech, Agnes
    Belleannee, Genevieve
    Gros, Audrey
    Italiano, Antoine
    Soubeyran, Isabelle
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (20) : E84 - E87
  • [7] Anaplastic lymphoma kinase rearrangement in surgically resected stage IA lung adenocarcinoma
    Shin, Sun Hye
    Lee, Hyun
    Jeong, Byeong-Ho
    Choi, Yong Soo
    Shin, Myung-Hee
    Kim, Seonwoo
    Han, Joungho
    Lee, Kyung Soo
    Shim, Young Mog
    Kwon, O. Jung
    Kim, Hojoong
    JOURNAL OF THORACIC DISEASE, 2018, 10 (06) : 3460 - 3467
  • [8] CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib
    Costa, Daniel B.
    Kobayashi, Susumu
    Pandya, Shuchi S.
    Yeo, Wee-Lee
    Shen, Zhongzhou
    Tan, Weiwei
    Wilner, Keith D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : E443 - E445
  • [9] EMT in anaplastic component of the pancreatic ductal adenocarcinoma
    Setdikova, G.
    Paklina, O.
    Sotnikova, T.
    VIRCHOWS ARCHIV, 2017, 471 : S131 - S131
  • [10] Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives
    Lee, James A.
    Bubendorf, Lukas
    Stahel, Rolf
    Peters, Solange
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (05) : 625 - 636
12345